Thursday, 15 October 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

HOTELS DE PARIS Stock Went Up By Over 29% In The Last 21 Sessions

Loading stream...

(vianews) - shares of hotels de paris (cac 40: hdp.pa) jumped by a staggering 29.57% in 21 sessions from €1.15 to €1.49 at 13:55 est on monday, following the last session's upward trend. cac 40 is falling 0.19% to €7,333.92, following the last session's downward trend.

about hotels de paris

les hôtels de paris sa operates and manages hotels in paris. as of december 31, 2021, it operated 17 hotels in paris, 1 hotel in st tropez, and 1 hotel in marrakech. the company was incorporated in 1992 and is headquartered in paris, france.

more news about hotels de paris (hdp.pa).

Categories

stockMarket

Tags

Stock PriceMarket Session NowHDP.PAStock Market NowPrice UpMarket SessionStock Price UpHOTELS DE PARISStock MarketStock
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com